Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Waters

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
Singapore Medical Journal|July 22, 2016
Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspectivePeter Yan, Eng Kiat Kevin Tan, Jason Chon Jun Choo, et al.
The American Journal of Cardiology|December 13, 2016
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL TrialSripal Bangalore, Rana Fayyad, Franz H Messerli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2007
Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Journal of Women'S Health (2002)|June 10, 2008
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?Todd M Brown, Dhananjay Vaidya, William J Rogers, et al.
The American Journal of Cardiology|December 7, 2010
Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials)Paul Frey, David D Waters, David A DeMicco, et al.
Current Medical Research and Opinion|October 1, 2010
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2J Wouter Jukema, Cheng-Wen Chiang, Jean Ferrières, et al.
American Heart Journal|October 27, 2009
Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2Raul D Santos, David D Waters, Lisa Tarasenko, et al.
The American Journal of Cardiology|November 11, 2008
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)Colleen Johnson, David D Waters, David A DeMicco, et al.
Circulation|March 17, 2004
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infectionPriscilla Y Hsue, Joan C Lo, Arlana Franklin, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The association between lipid levels and leukocyte count: A cross-sectional and longitudinal analysis of three large cohortsSonia Sawant, Bradley Tucker, Praween Senanayake, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
Singapore Medical Journal|July 22, 2016
Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspectivePeter Yan, Eng Kiat Kevin Tan, Jason Chon Jun Choo, et al.
The American Journal of Cardiology|December 13, 2016
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL TrialSripal Bangalore, Rana Fayyad, Franz H Messerli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2007
Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Journal of Women'S Health (2002)|June 10, 2008
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?Todd M Brown, Dhananjay Vaidya, William J Rogers, et al.
The American Journal of Cardiology|December 7, 2010
Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials)Paul Frey, David D Waters, David A DeMicco, et al.
Current Medical Research and Opinion|October 1, 2010
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2J Wouter Jukema, Cheng-Wen Chiang, Jean Ferrières, et al.
American Heart Journal|October 27, 2009
Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2Raul D Santos, David D Waters, Lisa Tarasenko, et al.
The American Journal of Cardiology|November 11, 2008
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)Colleen Johnson, David D Waters, David A DeMicco, et al.
Circulation|March 17, 2004
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infectionPriscilla Y Hsue, Joan C Lo, Arlana Franklin, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
The association between lipid levels and leukocyte count: A cross-sectional and longitudinal analysis of three large cohortsSonia Sawant, Bradley Tucker, Praween Senanayake, et al.
Pageof 16